Hormonal therapy is generally recommended for patients with hormone receptor-positive cancers. For example, in breast cancer, patients who are estrogen receptor (ER) or progesterone receptor (PR) positive may benefit from these treatments. Similarly, men with advanced or recurrent prostate cancer may be candidates for androgen deprivation therapy.
